Novartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed ...
By Bhanvi Satija May 31 (Reuters) - Novartis said on Sunday that early data from its experimental actinium-based drug showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results